Overview
PGxAlly provides pharmacogenomic testing and interpretation services designed to help healthcare providers optimize medication selection and dosing based on individual genetic profiles. The company delivers actionable genetic insights to support precision medicine practices and improve patient therapeutic outcomes.
More in Genetic Testing
Latest industry news
Genomic Sovereignty in MENA: How the Region Is Building Its Own Precision Medicine Foundation
2026-10-12 · Industry
Vietnam's Gene Solutions Eyes Hong Kong IPO to Fund Southeast Asian Genomics Expansion
2026-10-11 · Industry
NeoGenomics FDA-Approved PTEN Test Raises the Question: Is the Stock Undervalued?
2026-10-10 · Product
Current Genetic Testing in Cancer May Miss Most Inherited Gene Variants, Study Warns
2026-10-09 · Research
Company details
Is this your company?
Claim this listing to add your logo, full description, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach genomics professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →